India's Most Trusted Source for Effluent Treatment Plants — 340+ Verified Manufacturers, CPCB-Compliant Solutions for Every Industry and Discharge Standard
Trade4Asia maps 340+ verified Effluent Treatment Plant (ETP) manufacturers across India — from compact 1 KLD physico-chemical ETPs for small electroplating workshops to 10,000 KLD combined biological-physico-chemical ETPs for large textile mills, pharmaceutical and API manufacturing ETPs meeting CDSCO and CPCB standards, food and beverage ETPs with anaerobic pre-treatment for high-BOD effluents, chemical plant ETPs handling toxic and refractory organic compounds, common ETPs (CETPs) for industrial estate multi-user treatment, STP (sewage treatment plants) for residential and commercial complexes, and complete MBR (Membrane Bioreactor) based ETPs for space-constrained high-quality treated water applications. Whether you are installing a new ETP to meet CPCB consent conditions, upgrading an existing ETP for ZLD compliance, or commissioning a pharmaceutical wastewater system meeting Schedule M requirements, find manufacturers with verified treatment efficiency data, CPCB outlet standard compliance documentation, and process design engineering capability.
Ask Price
We are one of the foremost manufacturers of premium e of the foremost manufacturers of premium
Ask Price
We are one of the foremost manufacturers of premium e of the foremost manufacturers of premium
Ask Price
We are one of the foremost manufacturers of premium e of the foremost manufacturers of premium
Ask Price
We are one of the foremost manufacturers of premium e of the foremost manufacturers of premium
Relative Category
An effluent treatment plant designed without a thorough characterisation of the wastewater — its flow rate, BOD, COD, TSS, pH, specific toxic contaminants, and variability over the production cycle — will fail to achieve the required discharge standards even when built correctly. The most common ETP design failure in India is undersizing the biological treatment stage (aeration tank and clarifier) based on estimated flow and organic load rather than measured values. A pharmaceutical ETP designed for 500 kg BOD/day on plant production estimates but receiving 1,200 kg BOD/day from actual operations will consistently exceed CPCB BOD discharge limits of 30 mg/L — creating consent violation risk, SPCB closure notices, and expensive retrofitting costs that exceed what proper design would have cost initially. Biological treatment technology selection is the second most consequential design decision. The choice between activated sludge (AS), Moving Bed Biofilm Reactor (MBBR), Sequencing Batch Reactor (SBR), Membrane Bioreactor (MBR), and Extended Aeration depends on effluent characteristics, space available, treated water quality requirement, and operational complexity tolerance. For textile effluents with recalcitrant reactive dyes that resist biological degradation, biological treatment alone cannot achieve CPCB colour discharge norms — advanced treatment (ozonation, Fenton oxidation, or activated carbon polishing) is always required downstream of biological treatment. An ETP supplier who proposes only biological treatment for textile colour effluent without advanced oxidation polishing is proposing an inadequate solution. India's ETP market is growing at 15.2% CAGR, driven by CPCB enforcement strengthening, ZLD mandates for textile, distillery, and tannery industries, pharmaceutical PLI creating new ETP demand, and the NCAP ambient air quality programme's indirect effect of strengthening environmental enforcement across all industrial categories. The market ranges from genuine environmental engineering companies to civil contractors with ETP signage who lack the process engineering capability to design effective biological treatment systems.
